ARTICLE | Company News
TNI BioTech, LDN Research deal
January 14, 2013 8:00 AM UTC
TNI BioTech received exclusive rights to patents developed by Dr. Jill Smith and LDN relating to treatments for opioid antagonists, such as naltrexone, to treat inflammatory and ulcerative diseases of...